Project Details
Description
Demonstrating the potential for using gene therapy to treat human patients with retinitis pigmentosa (RP) caused by PDE6A mutations.
| Status | Active |
|---|---|
| Effective start/end date | 1/1/13 → … |
Funding
- Research to Prevent Blindness: US$100,000.00
ASJC Scopus Subject Areas
- Molecular Biology
- Medicine(all)
- Ophthalmology
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.